CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies
Diogo Gomes‐Silva(University of Lisbon), Maksim Mamonkin(Baylor College of Medicine)
Cited by 459
Related Papers
Chimeric antigen receptor-induced antigen loss protects CD5.CART cells from fratricide without compromising on-target cytotoxicity
|Cell Reports Medicine|2024|12
Enhancing CAR- and TCR-mediated targeting of cancer via an immune synapse-stabilizing receptor
|Nature Communications|2026|0